Surprise and balance billing reform efforts have been a subject of ongoing debate at the federal lev...
“Transactional diligence for physician services, post-acute care, and life sciences requires informed, data-driven evaluations from every angle.”
Mitigate Risk and Quantify Opportunities
Led by former Wall Street and private equity executives and complemented by expert healthcare policy, reimbursement, and commercialization advisors, our research group goes beyond the surface using public and proprietary data products to support private equity and sell-side investment decisions. Thinking like investors, we deliver customized, deep, data-driven analysis to quantify relevant risks, opportunities, and trends to inform financial models and potential goal achievement.
Whether you represent a PE firm, investment bank, or strategic investor, we can help you manage and measure the headwind and tailwind risks facing the contemplated investment.
Medicare and Commercial Data Analysis
Medicare and Commercial Reimbursement Assessments
Payer and Provider Interviews and Surveys
Portfolio Company and Competitive Analyses
Quantified Policy Impacts